Patient Portal

Stephanie Markovina, MD, PhD

Assistant Professor, Radiation Oncology

Specialty Areas

Gynecologic Oncology
Anal Cancer
Thyroid Cancer

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Gynecologic oncology, thyroid cancer, anal cancer and brachytherapy.

  • Location(s)
  • Education
  • Publication & Research

Location(s)

Location(s)

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129

Office Phone: 314-747-7222
Additional Phone: 800-600-3606

Center for Advanced Medicine
Radiation Oncology Center

4921 Parkview Place
St. Louis, MO 63110

Suite: LL

Education

Education

Residency, Radiation Oncology: Washington University School of Medicine, St. Louis, MO 2015
Medical Degree: University of Wisconsin School of Medicine & Public Health, Madison, WI 2011
PhD, Cellular and Molecular Biology: University of Wisconsin Madison, Madison, WI 2008
BS, Biology: Washington University, St. Louis, MO 2001

Publication & Research

Publication & Research

Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.
Lin AJ, Samson P, Zoberi J, Garcia-Ramirez J, Williamson JF, Markovina S, Schwarz J, Grigsby PW
Brachytherapy. 2019 Jan 14; pii: S1538-4721(18)30682-2. doi: 10.1016/j.brachy.2018.11.008.

PMID:
    30971370
    [PubMed - as supplied by publisher]
Related citations


Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities.
Patel RB, Baniel CC, Sriramaneni RN, Bradley K, Markovina S, Morris ZS
Brachytherapy. 2019 Mar - Apr; 18(2)240. doi: 10.1016/j.brachy.2019.01.004.

PMID:
    30914131
    [PubMed - in process]
Related citations


Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
Lin AJ, Ma S, Markovina S, Schwarz J, Mutch DG, Powell MA, Grigsby PW
Gynecol Oncol. 2019 Mar 21; pii: S0090-8258(19)30297-5. doi: 10.1016/j.ygyno.2019.03.104.

PMID:
    30905434
    [PubMed - as supplied by publisher]
Related citations


Detection of distant metastatic disease by positron emission tomography with <sup>18</sup>F-fluorodeoxyglucose (FDG-PET) at initial staging of cervical carcinoma.
Lin A, Ma S, Dehdashti F, Markovina S, Schwarz J, Siegel B, Powell M, Grigsby P
Int J Gynecol Cancer. 2019 Mar; 29(3)487-491. doi: 10.1136/ijgc-2018-000108.

PMID:
    30739082
    [PubMed - in process]
Related citations


Brachytherapy and survival in small cell cancer of the cervix and uterus.
Lin AJ, Hassanzadeh C, Markovina S, Schwarz J, Grigsby P
Brachytherapy. 2019 Mar - Apr; 18(2)163-170. doi: 10.1016/j.brachy.2018.11.006.

PMID:
    30563743
    [PubMed - in process]
Related citations


A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer.
Lin AJ, Samson P, DeWees T, Henke L, Baranski T, Schwarz J, Pfeifer J, Grigsby P, Markovina S
Cancer Med. 2019 Jan; 8(1)437-446. doi: 10.1002/cam4.1857.

PMID:
    30552739
    [PubMed - in process]
Related citations


Intensity Modulated Radiation Therapy and Image-Guided Adapted Brachytherapy for Cervix Cancer.
Lin AJ, Kidd E, Dehdashti F, Siegel BA, Mutic S, Thaker PH, Massad LS, Powell MA, Mutch DG, Markovina S, Schwarz J, Grigsby PW
Int J Radiat Oncol Biol Phys. 2019 Apr 1; 103(5)1088-1097. doi: 10.1016/j.ijrobp.2018.11.012.

PMID:
    30445171
    [PubMed - in process]
Related citations


Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities.
Patel RB, Baniel CC, Sriramaneni RN, Bradley K, Markovina S, Morris ZS
Brachytherapy. 2018 Nov - Dec; 17(6)995-1003. doi: 10.1016/j.brachy.2018.07.004.

PMID:
    30078541
    [PubMed - in process]
Related citations


Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis.
Markovina S, Meeks MW, Badiyan S, Vetter J, Gay HA, Paradis A, Michalski J, Sandhu G
Adv Radiat Oncol. 2018 Apr-Jun; 3(2)190-196. doi: 10.1016/j.adro.2017.12.001.

PMID:
    29904744
    [PubMed]
Related citations


Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer.
Grigsby P, Elhammali A, Ruiz F, Markovina S, McLellan MD, Miller CA, Chundury A, Ta NL, Rashmi R, Pfeifer JD, Fulton RS, DeWees T, Schwarz JK
Oncotarget. 2018 Jan 9; 9(3)4061-4073. doi: 10.18632/oncotarget.23664.

PMID:
    29423104
    [PubMed]
Related citations


Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma.
Huynh M, Pak C, Markovina S, Callander NS, Chng KS, Wuerzberger-Davis SM, Bakshi DD, Kink JA, Hematti P, Hope C, Asimakopoulos F, Rui L, Miyamoto S
J Biol Chem. 2018 Feb 16; 293(7)2452-2465. doi: 10.1074/jbc.RA117.000667.

PMID:
    29279332
    [PubMed - indexed for MEDLINE]
Related citations


Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus.
Cardenas ML, Spencer CR, Markovina S, DeWees TA, Mazur TR, Weiner AA, Parikh PJ, Olsen JR
Adv Radiat Oncol. 2017 Jul-Sep; 2(3)281-287. doi: 10.1016/j.adro.2017.04.007.

PMID:
    29114593
    [PubMed]
Related citations


Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.
Markovina S, Wang S, Henke LE, Luke CJ, Pak SC, DeWees T, Pfeifer JD, Schwarz JK, Liu W, Chen S, Mutch D, Wang X, Powell MA, Siegel BA, Dehdashti F, Silverman GA, Grigsby PW
Br J Cancer. 2018 Jan; 118(1)72-78. doi: 10.1038/bjc.2017.390.

PMID:
    29112685
    [PubMed - indexed for MEDLINE]
Related citations


Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S, Youssef F, Roy A, Aggarwal S, Khwaja S, DeWees T, Tan B, Hunt S, Myerson RJ, Chang DT, Parikh PJ, Olsen JR
Int J Radiat Oncol Biol Phys. 2017 Oct 1; 99(2)417-426. doi: 10.1016/j.ijrobp.2017.05.048.

PMID:
    28871992
    [PubMed - indexed for MEDLINE]
Related citations


Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.
Rao YJ, Chin RI, Hui C, Mutch DG, Powell MA, Schwarz JK, Grigsby PW, Markovina S
Gynecol Oncol. 2017 Sep; 146(3)572-579. doi: 10.1016/j.ygyno.2017.06.022.

PMID:
    28662775
    [PubMed - indexed for MEDLINE]
Related citations


Quality of Life Outcomes From a Phase 2 Trial of Short-Course Radiation Therapy Followed by FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer.
Khwaja SS, Roy A, Markovina S, Dewees TA, Hunt S, Tan B, Myerson RJ, Olsen JR, Parikh PJ
Int J Radiat Oncol Biol Phys. 2016 Aug 1; 95(5)1429-1438. doi: 10.1016/j.ijrobp.2016.03.020.

PMID:
    27209506
    [PubMed - indexed for MEDLINE]
Related citations


Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235.
Markovina S, Duan F, Snyder BS, Siegel BA, Machtay M, Bradley JD
Int J Radiat Oncol Biol Phys. 2015 Nov 1; 93(3)597-605. doi: 10.1016/j.ijrobp.2015.04.026.

PMID:
    26461002
    [PubMed - indexed for MEDLINE]
Related citations


Rebuttal to Drs. Hussein and Cooperberg.
Markovina S, Michalski J
Brachytherapy. 2015 Nov-Dec; 14(6)763-5. doi: 10.1016/j.brachy.2015.06.010.

PMID:
    26235200
    [PubMed - indexed for MEDLINE]
Related citations


Counterpoint: Unfair comparisons lead to unwarranted conclusions-Can treatment modalities for localized prostate cancer truly be compared without bias?
Markovina S, Michalski J
Brachytherapy. 2015 Nov-Dec; 14(6)756-60. doi: 10.1016/j.brachy.2015.06.009.

PMID:
    26219833
    [PubMed - indexed for MEDLINE]
Related citations


Low incidence of new biochemical hypogonadism after intensity modulated radiation therapy for prostate cancer.
Markovina S, Weschenfelder DC, Gay H, McCandless A, Carey B, DeWees T, Knutson N, Michalski J
Pract Radiat Oncol. 2014 Nov-Dec; 4(6)430-6. doi: 10.1016/j.prro.2014.02.004.

PMID:
    25407866
    [PubMed - indexed for MEDLINE]
Related citations

Areas of Research Interest

Cancer biology